Latest News for XBI
Biotech has long been one of the strongest sector stories of the past year, and investors who got there early have been rewarded.
The biotech industry has been a robust roller-coaster over the last half decade.
The bulk of coverage towards the top gaining stock sectors over the past year has focused understandably on technology, which has made huge strides, with semiconductors exceeding +60%. However, the biotech sector has gained +33-35% in the same period - and many predict things are just getting started. For those seeking a broad biotech exposure,... Biotech Stocks Are Up About 35% in the Past Year and Analysts Say the…
The bulk of coverage towards the top gaining stock sectors over the past year has focused understandably on technology, which has made huge strides, with semiconductors exceeding +60%.
The State Street SPDR S&P Biotech ETF (XBI) was launched on 01/31/2006, and is a smart beta exchange traded fund designed to offer broad exposure to the Health Care ETFs category of the market.
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for XBI.
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.